{"id": "article-27913_0", "title": "Prurigo Nodularis -- Continuing Education Activity", "content": "Prurigo nodularis (PN) is a chronic skin disorder characterized by multiple, firm, flesh-to-pink colored papules, plaques, and nodules predominantly found on the extensor surfaces of the extremities. These lesions are intensely\u00a0pruritic and\u00a0manifest across diverse age groups. PN often coexists with other cutaneous hypersensitivity disorders, such as atopic dermatitis or chronic pruritus, making its diagnosis primarily clinical yet necessitating differentiation from similar conditions like lichen simplex chronicus\u00a0or\u00a0hypertrophic lichen planus. Dermoscopy and histopathology serve as crucial tools for diagnostic confirmation in challenging cases.", "contents": "Prurigo Nodularis -- Continuing Education Activity. Prurigo nodularis (PN) is a chronic skin disorder characterized by multiple, firm, flesh-to-pink colored papules, plaques, and nodules predominantly found on the extensor surfaces of the extremities. These lesions are intensely\u00a0pruritic and\u00a0manifest across diverse age groups. PN often coexists with other cutaneous hypersensitivity disorders, such as atopic dermatitis or chronic pruritus, making its diagnosis primarily clinical yet necessitating differentiation from similar conditions like lichen simplex chronicus\u00a0or\u00a0hypertrophic lichen planus. Dermoscopy and histopathology serve as crucial tools for diagnostic confirmation in challenging cases."}
{"id": "article-27913_1", "title": "Prurigo Nodularis -- Continuing Education Activity", "content": "Management of PN encompasses a multifaceted approach involving potent antipruritics, immunomodulators, and neuromodulators tailored to patients' specific needs.\u00a0Long-term therapy is often necessary as PN tends to be refractory to conventional treatments, emphasizing the importance of patient education, counseling, and compliance.\u00a0This activity reviews the evaluation and comprehensive management strategies for PN, highlighting the role of the interprofessional team in caring for patients with this debilitating skin condition, considering both its physical and psychological ramifications.", "contents": "Prurigo Nodularis -- Continuing Education Activity. Management of PN encompasses a multifaceted approach involving potent antipruritics, immunomodulators, and neuromodulators tailored to patients' specific needs.\u00a0Long-term therapy is often necessary as PN tends to be refractory to conventional treatments, emphasizing the importance of patient education, counseling, and compliance.\u00a0This activity reviews the evaluation and comprehensive management strategies for PN, highlighting the role of the interprofessional team in caring for patients with this debilitating skin condition, considering both its physical and psychological ramifications."}
{"id": "article-27913_2", "title": "Prurigo Nodularis -- Continuing Education Activity", "content": "Objectives: Identify the etiology of prurigo nodularis (PN), including its association with diverse cutaneous hypersensitivity disorders like atopic dermatitis, chronic pruritus, and other potential underlying conditions. Evaluate PN lesions through history, examination, and lab testing to confirm diagnosis and differentiate them from other dermatological conditions with similar clinical presentations. Determine the treatment plan and management options available for PN based on individual patient needs and the chronic, refractory nature of the condition. Collaborate with the interprofessional team to optimize management strategies for improved patient outcomes. Access free multiple choice questions on this topic.", "contents": "Prurigo Nodularis -- Continuing Education Activity. Objectives: Identify the etiology of prurigo nodularis (PN), including its association with diverse cutaneous hypersensitivity disorders like atopic dermatitis, chronic pruritus, and other potential underlying conditions. Evaluate PN lesions through history, examination, and lab testing to confirm diagnosis and differentiate them from other dermatological conditions with similar clinical presentations. Determine the treatment plan and management options available for PN based on individual patient needs and the chronic, refractory nature of the condition. Collaborate with the interprofessional team to optimize management strategies for improved patient outcomes. Access free multiple choice questions on this topic."}
{"id": "article-27913_3", "title": "Prurigo Nodularis -- Introduction", "content": "Prurigo nodularis (PN) is a chronic disorder of the skin that is classically seen as multiple, firm, flesh-to-pink-colored nodules commonly located on the extensor surfaces of the extremities. The lesions are\u00a0very pruritic, and the condition may occur in any age group. It is commonly associated with another disorder of cutaneous hypersensitivity, such as atopic dermatitis or chronic pruritus of diverse origins. The diagnosis is mainly clinical, although certain conditions may simulate it clinically, warranting differentiation. The condition is associated with significant physical and psychological morbidity and is often refractory to treatments. A wide range of general measures, pharmacological approaches, and psychological therapies may be needed in a patient with advanced PN. [1] [2] [3] [4]", "contents": "Prurigo Nodularis -- Introduction. Prurigo nodularis (PN) is a chronic disorder of the skin that is classically seen as multiple, firm, flesh-to-pink-colored nodules commonly located on the extensor surfaces of the extremities. The lesions are\u00a0very pruritic, and the condition may occur in any age group. It is commonly associated with another disorder of cutaneous hypersensitivity, such as atopic dermatitis or chronic pruritus of diverse origins. The diagnosis is mainly clinical, although certain conditions may simulate it clinically, warranting differentiation. The condition is associated with significant physical and psychological morbidity and is often refractory to treatments. A wide range of general measures, pharmacological approaches, and psychological therapies may be needed in a patient with advanced PN. [1] [2] [3] [4]"}
{"id": "article-27913_4", "title": "Prurigo Nodularis -- Etiology", "content": "The exact etiology of\u00a0PN remains poorly understood. Although the role of the unimpeded itch-scratch cycle is uncontested, the exact sequence of events leading to the final clinical picture remains debated.\u00a0PN is accompanied by long-standing pruritus and is thought to develop as a reaction to repeated scratching in patients with chronic prurigo of various etiologies, including dermatological, systemic, infectious, and neuropsychiatric. [5] [6] Anecdotal data suggest a causative role or association of infectious agents\u00a0such as hepatitis C, Helicobacter pylori, Strongyloides stercoralis, mycobacteria, and HIV. [7] [8]", "contents": "Prurigo Nodularis -- Etiology. The exact etiology of\u00a0PN remains poorly understood. Although the role of the unimpeded itch-scratch cycle is uncontested, the exact sequence of events leading to the final clinical picture remains debated.\u00a0PN is accompanied by long-standing pruritus and is thought to develop as a reaction to repeated scratching in patients with chronic prurigo of various etiologies, including dermatological, systemic, infectious, and neuropsychiatric. [5] [6] Anecdotal data suggest a causative role or association of infectious agents\u00a0such as hepatitis C, Helicobacter pylori, Strongyloides stercoralis, mycobacteria, and HIV. [7] [8]"}
{"id": "article-27913_5", "title": "Prurigo Nodularis -- Etiology", "content": "An increase in the number of sensory structures of the epidermis (Merkel cells) and dermis (papillary dermal nerves) is encountered in PN lesions. [9] This neural alteration is typical of PN and not seen in lichen simplex chronicus or neurodermatitis.\u00a0The density of mast cells and neutrophils is also increased in PN, although there seems to be no increase in their degranulation products. In contrast,\u00a0although the number of eosinophils remains maintained, their products, such as the major basic protein and eosinophil-derived neurotoxin, show higher than normal levels.", "contents": "Prurigo Nodularis -- Etiology. An increase in the number of sensory structures of the epidermis (Merkel cells) and dermis (papillary dermal nerves) is encountered in PN lesions. [9] This neural alteration is typical of PN and not seen in lichen simplex chronicus or neurodermatitis.\u00a0The density of mast cells and neutrophils is also increased in PN, although there seems to be no increase in their degranulation products. In contrast,\u00a0although the number of eosinophils remains maintained, their products, such as the major basic protein and eosinophil-derived neurotoxin, show higher than normal levels."}
{"id": "article-27913_6", "title": "Prurigo Nodularis -- Etiology", "content": "The pruritus in PN seems to be a result of cutaneous\u00a0neurogenic inflammation mediated by various neuropeptides, especially substance P, calcitonin gene\u2013related peptide (CGRP), [10] and\u00a0vanilloid receptor subtype 1 (VR-1). The latter binds to capsaicin, rendering it a potential therapeutic topical agent. Individuals with PN also show elevated levels of interleukin 31 (IL-31), a T-cell\u2013derived highly prurigogenic cytokine. [11]", "contents": "Prurigo Nodularis -- Etiology. The pruritus in PN seems to be a result of cutaneous\u00a0neurogenic inflammation mediated by various neuropeptides, especially substance P, calcitonin gene\u2013related peptide (CGRP), [10] and\u00a0vanilloid receptor subtype 1 (VR-1). The latter binds to capsaicin, rendering it a potential therapeutic topical agent. Individuals with PN also show elevated levels of interleukin 31 (IL-31), a T-cell\u2013derived highly prurigogenic cytokine. [11]"}
{"id": "article-27913_7", "title": "Prurigo Nodularis -- Epidemiology", "content": "The exact incidence of\u00a0PN is unknown. A majority of patients with\u00a0PN present between the ages of 51 and 65 years, although several cases in other age groups have also been described. [5] [12] The disease afflicts both genders; however,\u00a0it seems to be more frequent and more intense in females. [13] Multiple studies have shown that individuals with an atopic predisposition have an earlier age of onset. [5] [14] [15] Ethnicity and genetic predisposition seem to play a role since African-Americans are 3 to 4 times more likely to have\u00a0PN than white patients. [12] Other\u00a0conditions that have been reported to induce\u00a0PN include internal malignancy, renal failure, and psychiatric conditions. In HIV-positive patients,\u00a0PN\u00a0has been reported to be predictive of advanced immunosuppression. [16]", "contents": "Prurigo Nodularis -- Epidemiology. The exact incidence of\u00a0PN is unknown. A majority of patients with\u00a0PN present between the ages of 51 and 65 years, although several cases in other age groups have also been described. [5] [12] The disease afflicts both genders; however,\u00a0it seems to be more frequent and more intense in females. [13] Multiple studies have shown that individuals with an atopic predisposition have an earlier age of onset. [5] [14] [15] Ethnicity and genetic predisposition seem to play a role since African-Americans are 3 to 4 times more likely to have\u00a0PN than white patients. [12] Other\u00a0conditions that have been reported to induce\u00a0PN include internal malignancy, renal failure, and psychiatric conditions. In HIV-positive patients,\u00a0PN\u00a0has been reported to be predictive of advanced immunosuppression. [16]"}
{"id": "article-27913_8", "title": "Prurigo Nodularis -- Pathophysiology", "content": "The pathophysiology of\u00a0PN has been controversial.\u00a0Chronic or recurrent mechanical trauma or vigorous frictional assault to the skin induces epidermal hyperplasia with resultant thickening of the skin. Repetitive mechanical rubbing\u00a0and scratching of the skin result in the formation of plaques and nodules\u00a0(often with lichenification)\u00a0and also give rise to dyschromic changes\u00a0(typically hyperpigmentation). The itching of PN is typically episodic, severe, and uncontrollable; it tends to occur at discrete points that eventually transform into hyperpigmented nodular plaques with excoriations, crusting, and sometimes secondary bacterial infection.", "contents": "Prurigo Nodularis -- Pathophysiology. The pathophysiology of\u00a0PN has been controversial.\u00a0Chronic or recurrent mechanical trauma or vigorous frictional assault to the skin induces epidermal hyperplasia with resultant thickening of the skin. Repetitive mechanical rubbing\u00a0and scratching of the skin result in the formation of plaques and nodules\u00a0(often with lichenification)\u00a0and also give rise to dyschromic changes\u00a0(typically hyperpigmentation). The itching of PN is typically episodic, severe, and uncontrollable; it tends to occur at discrete points that eventually transform into hyperpigmented nodular plaques with excoriations, crusting, and sometimes secondary bacterial infection."}
{"id": "article-27913_9", "title": "Prurigo Nodularis -- Pathophysiology", "content": "Immunohistochemical studies have shown increased dermal nerve fibers in the papillary dermis of patients with PN. It has been postulated that the thin, unmyelinated epidermal nerves are the transmitters of severe prurigo. Nerve growth factor (NGF) and its receptor, tyrosine receptor kinase A (TrkA), are overexpressed in PN lesions; both\u00a0may also be associated with the increased release and accumulation of neuropeptides, such as substance P and calcitonin gene\u2013related peptides. [17] Interestingly, skin biopsies taken from lesions of PN tend to show\u00a0significantly decreased intraepidermal\u2014not dermal\u2014nerve fiber density. Although this finding has raised doubt about some subclinical small nerve fiber neuropathy contributing to the pathophysiology of PN, recent studies have suggested that\u00a0the reduction may be secondary to chronic scratching. This suggestion was confirmed by observing restoration of the intraepidermal\u00a0nerve fiber density on complete healing of lesions. [18]", "contents": "Prurigo Nodularis -- Pathophysiology. Immunohistochemical studies have shown increased dermal nerve fibers in the papillary dermis of patients with PN. It has been postulated that the thin, unmyelinated epidermal nerves are the transmitters of severe prurigo. Nerve growth factor (NGF) and its receptor, tyrosine receptor kinase A (TrkA), are overexpressed in PN lesions; both\u00a0may also be associated with the increased release and accumulation of neuropeptides, such as substance P and calcitonin gene\u2013related peptides. [17] Interestingly, skin biopsies taken from lesions of PN tend to show\u00a0significantly decreased intraepidermal\u2014not dermal\u2014nerve fiber density. Although this finding has raised doubt about some subclinical small nerve fiber neuropathy contributing to the pathophysiology of PN, recent studies have suggested that\u00a0the reduction may be secondary to chronic scratching. This suggestion was confirmed by observing restoration of the intraepidermal\u00a0nerve fiber density on complete healing of lesions. [18]"}
{"id": "article-27913_10", "title": "Prurigo Nodularis -- Pathophysiology", "content": "The role of helper T cytokines (T helper 1 [Th1] and T helper 2 [Th2]) has also been studied in the pathogenesis of PN using the signal transducers and activators of transcription (STAT) 1, 3, and 6. In\u00a0all but 3 cases, the entire epidermis was stained with anti\u2013phosphorylated STAT (pSTAT) 6, a marker for the Th2 cytokines IL-4, IL-5, and IL-13. These findings suggest that Th2 cytokines play a principal role in the pathogenesis of PN. [19]", "contents": "Prurigo Nodularis -- Pathophysiology. The role of helper T cytokines (T helper 1 [Th1] and T helper 2 [Th2]) has also been studied in the pathogenesis of PN using the signal transducers and activators of transcription (STAT) 1, 3, and 6. In\u00a0all but 3 cases, the entire epidermis was stained with anti\u2013phosphorylated STAT (pSTAT) 6, a marker for the Th2 cytokines IL-4, IL-5, and IL-13. These findings suggest that Th2 cytokines play a principal role in the pathogenesis of PN. [19]"}
{"id": "article-27913_11", "title": "Prurigo Nodularis -- Histopathology", "content": "PN lesions under histopathology can show thick orthohyperkeratosis, irregular epidermal hyperplasia, and pseudoepitheliomatous hyperplasia. Focal parakeratosis with irregular acanthosis, diminished nerve fiber density, and a nonspecific dermal infiltrate containing lymphocytes, macrophages, eosinophils, and neutrophils may also be seen.", "contents": "Prurigo Nodularis -- Histopathology. PN lesions under histopathology can show thick orthohyperkeratosis, irregular epidermal hyperplasia, and pseudoepitheliomatous hyperplasia. Focal parakeratosis with irregular acanthosis, diminished nerve fiber density, and a nonspecific dermal infiltrate containing lymphocytes, macrophages, eosinophils, and neutrophils may also be seen."}
{"id": "article-27913_12", "title": "Prurigo Nodularis -- Histopathology", "content": "Histology can be important in\u00a0differentiating PN\u00a0from lichen simplex (LS) and hypertrophic lichen planus (HLP). LS\u00a0lesions are less likely to have pseudoepitheliomatous hyperplasia or nerve fiber thickening; however, these findings do not rule out the histological diagnosis of PN. To reliably distinguish between PN and LS, it is necessary to correlate clinical and histological findings. [20]", "contents": "Prurigo Nodularis -- Histopathology. Histology can be important in\u00a0differentiating PN\u00a0from lichen simplex (LS) and hypertrophic lichen planus (HLP). LS\u00a0lesions are less likely to have pseudoepitheliomatous hyperplasia or nerve fiber thickening; however, these findings do not rule out the histological diagnosis of PN. To reliably distinguish between PN and LS, it is necessary to correlate clinical and histological findings. [20]"}
{"id": "article-27913_13", "title": "Prurigo Nodularis -- Histopathology", "content": "HLP and PN both demonstrate epidermal hyperplasia, hypergranulosis, and compact hyperkeratosis. Vertically arranged collagen fibers and increased fibroblasts and capillaries in the dermis are found in both conditions. However, basal cell degeneration is limited to the tips of rete ridges, and no band-like inflammation will be seen in HLP\u00a0versus PN [21]", "contents": "Prurigo Nodularis -- Histopathology. HLP and PN both demonstrate epidermal hyperplasia, hypergranulosis, and compact hyperkeratosis. Vertically arranged collagen fibers and increased fibroblasts and capillaries in the dermis are found in both conditions. However, basal cell degeneration is limited to the tips of rete ridges, and no band-like inflammation will be seen in HLP\u00a0versus PN [21]"}
{"id": "article-27913_14", "title": "Prurigo Nodularis -- History and Physical", "content": "Patients with PN present with characteristic firm, dome-shaped, pruritic nodules that vary from a few millimeters to a few centimeters. The nodules can be flesh-colored, erythematous, pink, and brown/black. The lesions can begin as normal skin or areas of xerosis; patients will scratch\u00a0them\u00a0due to pruritus until the dome-shaped nodule forms. Typically, the lesions are found symmetrically on the extensor surfaces of the arm and legs. [22] Lesions can also be found in the occipital region of the scalp. The upper back, abdomen, and sacrum also can be involved.", "contents": "Prurigo Nodularis -- History and Physical. Patients with PN present with characteristic firm, dome-shaped, pruritic nodules that vary from a few millimeters to a few centimeters. The nodules can be flesh-colored, erythematous, pink, and brown/black. The lesions can begin as normal skin or areas of xerosis; patients will scratch\u00a0them\u00a0due to pruritus until the dome-shaped nodule forms. Typically, the lesions are found symmetrically on the extensor surfaces of the arm and legs. [22] Lesions can also be found in the occipital region of the scalp. The upper back, abdomen, and sacrum also can be involved."}
{"id": "article-27913_15", "title": "Prurigo Nodularis -- History and Physical", "content": "Areas of the body that are difficult to reach, such as the upper mid-back, are usually spared from PN lesions, a finding called the \u201cbutterfly sign.\u201d The palms, soles, face, and flexural areas are also usually spared. PN lesions cause severe pruritus,\u00a0which can be very distressing for patients. It can be sporadic or continuous and can increase with sweating, clothing irritation, or heat. In\u00a0addition to pruritic sensations, patients can experience burning, stinging, and alterations in lesional temperature. [5] It has been reported that in some cases, atopic dermatitis and xerosis are found in conjunction with\u00a0PN and may be the initiating factor.", "contents": "Prurigo Nodularis -- History and Physical. Areas of the body that are difficult to reach, such as the upper mid-back, are usually spared from PN lesions, a finding called the \u201cbutterfly sign.\u201d The palms, soles, face, and flexural areas are also usually spared. PN lesions cause severe pruritus,\u00a0which can be very distressing for patients. It can be sporadic or continuous and can increase with sweating, clothing irritation, or heat. In\u00a0addition to pruritic sensations, patients can experience burning, stinging, and alterations in lesional temperature. [5] It has been reported that in some cases, atopic dermatitis and xerosis are found in conjunction with\u00a0PN and may be the initiating factor."}
{"id": "article-27913_16", "title": "Prurigo Nodularis -- History and Physical", "content": "Lesions can often appear excoriated due to the pruritus involved with PN. Excoriated lesions are at increased risk of secondary infection and can appear crusted, erythematous, or painful if infected.\u00a0PN can also be localized in\u00a0cases of underlying local dermatosis such as venous stasis, postherpetic neuralgia, or brachioradial pruritus. [23]", "contents": "Prurigo Nodularis -- History and Physical. Lesions can often appear excoriated due to the pruritus involved with PN. Excoriated lesions are at increased risk of secondary infection and can appear crusted, erythematous, or painful if infected.\u00a0PN can also be localized in\u00a0cases of underlying local dermatosis such as venous stasis, postherpetic neuralgia, or brachioradial pruritus. [23]"}
{"id": "article-27913_17", "title": "Prurigo Nodularis -- Evaluation", "content": "PN\u00a0is a clinical diagnosis. Patients with PN will likely have a history of chronic severe pruritus with excoriations and flesh-colored, pink nodular lesions on extensor surfaces. Dermoscopy can be a helpful tool when diagnosing PN versus HLP. In one study, dermoscopy of HLP demonstrated pearly white areas and peripheral striations, gray-blue globules, comedo-like openings, red dots and globules, brownish-black globules, and yellowish structures. In PN, red dots and globules and pearly white areas with peripheral striations were observed under dermoscopy. [24] A skin biopsy may be warranted for lesions that are bleeding, have formed ulcers, or are resistant to first-line therapies.", "contents": "Prurigo Nodularis -- Evaluation. PN\u00a0is a clinical diagnosis. Patients with PN will likely have a history of chronic severe pruritus with excoriations and flesh-colored, pink nodular lesions on extensor surfaces. Dermoscopy can be a helpful tool when diagnosing PN versus HLP. In one study, dermoscopy of HLP demonstrated pearly white areas and peripheral striations, gray-blue globules, comedo-like openings, red dots and globules, brownish-black globules, and yellowish structures. In PN, red dots and globules and pearly white areas with peripheral striations were observed under dermoscopy. [24] A skin biopsy may be warranted for lesions that are bleeding, have formed ulcers, or are resistant to first-line therapies."}
{"id": "article-27913_18", "title": "Prurigo Nodularis -- Evaluation", "content": "In\u00a0patients with\u00a0PN and severe pruritus, underlying causes of severe pruritus should be evaluated,\u00a0including renal disease, liver disease, thyroid disease, HIV infection, malignancy, or parasitic infection. [25] Evaluation of these causes includes a complete blood cell count, complete metabolic panel, thyroid studies including\u00a0thyroid-stimulating hormone\u00a0and free thyroxine (T4), urinalysis, stool exam, HIV antibodies, and chest X-ray. Serum immunoglobulin E levels can also be elevated in patients with PN and atopic dermatitis. [26]", "contents": "Prurigo Nodularis -- Evaluation. In\u00a0patients with\u00a0PN and severe pruritus, underlying causes of severe pruritus should be evaluated,\u00a0including renal disease, liver disease, thyroid disease, HIV infection, malignancy, or parasitic infection. [25] Evaluation of these causes includes a complete blood cell count, complete metabolic panel, thyroid studies including\u00a0thyroid-stimulating hormone\u00a0and free thyroxine (T4), urinalysis, stool exam, HIV antibodies, and chest X-ray. Serum immunoglobulin E levels can also be elevated in patients with PN and atopic dermatitis. [26]"}
{"id": "article-27913_19", "title": "Prurigo Nodularis -- Treatment / Management", "content": "Management of PN requires a multifaceted approach. Patients need to be educated on practices to reduce scratching of lesions. Further, any\u00a0psychological disorder associated with scratching and picking at skin should be diagnosed\u00a0and treated. Any underlying causes of pruritus should also be diagnosed. Treatments for PN, both topical and systemic, are targeted at disrupting the itch-scratch cycle.", "contents": "Prurigo Nodularis -- Treatment / Management. Management of PN requires a multifaceted approach. Patients need to be educated on practices to reduce scratching of lesions. Further, any\u00a0psychological disorder associated with scratching and picking at skin should be diagnosed\u00a0and treated. Any underlying causes of pruritus should also be diagnosed. Treatments for PN, both topical and systemic, are targeted at disrupting the itch-scratch cycle."}
{"id": "article-27913_20", "title": "Prurigo Nodularis -- Treatment / Management -- General Care", "content": "Patients with PN should be advised to: Keep their nails short, wear protective clothing (ie, long sleeves and gloves), and keep the nodules covered with bandages. Bathe with\u00a0gentle cleansers and apply emollients\u00a0throughout day to keep skin moisturized. Use calamine lotions and lotions containing menthol and camphor\u00a0to\u00a0provide itch relief. Stay in a cool, comfortable environment. Reduce stress.", "contents": "Prurigo Nodularis -- Treatment / Management -- General Care. Patients with PN should be advised to: Keep their nails short, wear protective clothing (ie, long sleeves and gloves), and keep the nodules covered with bandages. Bathe with\u00a0gentle cleansers and apply emollients\u00a0throughout day to keep skin moisturized. Use calamine lotions and lotions containing menthol and camphor\u00a0to\u00a0provide itch relief. Stay in a cool, comfortable environment. Reduce stress."}
{"id": "article-27913_21", "title": "Prurigo Nodularis -- Treatment / Management -- Topical and Intralesional Therapy", "content": "Although none have been examined in randomized trials, topical treatments for\u00a0PN include class\u00a0I topical corticosteroids, intralesional corticosteroids, topical calcineurin inhibitors, topical capsaicin, and topical vitamin D analogs. The suggested first-line therapy\u00a0consists of\u00a0topical corticosteroids, such as clobetasol dipropionate 0.05% ointment, applied under occlusion with plastic wrap once at nighttime for at least\u00a02 to\u00a04 weeks. Triamcinolone acetonide, in concentrations of 10\u00a0mg/mL\u00a0to 20 mg/mL injected intralesionally, has been shown to flatten lesions and provide relief from pruritus. [27] [28] [29] [30] [31] Pimecrolimus 1% is as effective as hydrocortisone and can be implemented in a long-term regimen. [32] Calcipotriol ointment shows greater efficacy\u00a0than betamethasone valerate 0.1%. [33] Low concentrations of menthol (<5%) alleviate pruritus by heightening the threshold for pruritic stimuli. [34]", "contents": "Prurigo Nodularis -- Treatment / Management -- Topical and Intralesional Therapy. Although none have been examined in randomized trials, topical treatments for\u00a0PN include class\u00a0I topical corticosteroids, intralesional corticosteroids, topical calcineurin inhibitors, topical capsaicin, and topical vitamin D analogs. The suggested first-line therapy\u00a0consists of\u00a0topical corticosteroids, such as clobetasol dipropionate 0.05% ointment, applied under occlusion with plastic wrap once at nighttime for at least\u00a02 to\u00a04 weeks. Triamcinolone acetonide, in concentrations of 10\u00a0mg/mL\u00a0to 20 mg/mL injected intralesionally, has been shown to flatten lesions and provide relief from pruritus. [27] [28] [29] [30] [31] Pimecrolimus 1% is as effective as hydrocortisone and can be implemented in a long-term regimen. [32] Calcipotriol ointment shows greater efficacy\u00a0than betamethasone valerate 0.1%. [33] Low concentrations of menthol (<5%) alleviate pruritus by heightening the threshold for pruritic stimuli. [34]"}
{"id": "article-27913_22", "title": "Prurigo Nodularis -- Treatment / Management -- Antihistamines and Leukotriene Inhibitors", "content": "High-dose nonsedating antihistamines can be used\u00a0during the day, followed by first-generation sedating antihistamines at bedtime; a combination of fexofenadine and montelukast gives good results. [35] Common adverse reactions to antihistamines are drowsiness, dizziness, and weakness.", "contents": "Prurigo Nodularis -- Treatment / Management -- Antihistamines and Leukotriene Inhibitors. High-dose nonsedating antihistamines can be used\u00a0during the day, followed by first-generation sedating antihistamines at bedtime; a combination of fexofenadine and montelukast gives good results. [35] Common adverse reactions to antihistamines are drowsiness, dizziness, and weakness."}
{"id": "article-27913_23", "title": "Prurigo Nodularis -- Treatment / Management -- Phototherapy and Excimer Laser", "content": "Phototherapy with psoralen\u2013ultraviolet-A (PUVA), including bath\u00a0and topical PUVA, long-wavelength UVA, narrowband UVB, and monochromatic excimer light of 308 nm, have been used and shown improvement of\u00a0PN nodules. Narrow band UVB phototherapy significantly improves PN at an average dose of 23.88-26.00 j/cm 2 . [36] An excimer laser is more beneficial than topical clobetasol. [37]", "contents": "Prurigo Nodularis -- Treatment / Management -- Phototherapy and Excimer Laser. Phototherapy with psoralen\u2013ultraviolet-A (PUVA), including bath\u00a0and topical PUVA, long-wavelength UVA, narrowband UVB, and monochromatic excimer light of 308 nm, have been used and shown improvement of\u00a0PN nodules. Narrow band UVB phototherapy significantly improves PN at an average dose of 23.88-26.00 j/cm 2 . [36] An excimer laser is more beneficial than topical clobetasol. [37]"}
{"id": "article-27913_24", "title": "Prurigo Nodularis -- Treatment / Management -- Oral Immunosuppressants", "content": "As with topical therapies, no randomized trials have been reported involving these systemic therapies, and the benefits versus risks of the drugs must be considered before beginning treatment. [13] Oral immunosuppressive therapy should be considered for patients with severe, recalcitrant PN. A single-institution retrospective study demonstrated clinical improvement and decreased pruritus with cyclosporine at a mean dose of 3.1 mg/kg. [38] Methotrexate dosed at 5 to 20 mg/kg weekly demonstrated complete or partial remission of 2.4 months. These patients showed a mean duration of response of 19 months. [39] Treatment with azathioprine and cyclophosphamide has also been reported to be successful. [40] [41] Oral tacrolimus therapy dramatically reduced pruritus in a patient previously treated with cyclosporine. [42] Combination therapy of\u00a03 cycles of intravenous immunoglobulin followed by methotrexate and topical steroids was effective in treating PN associated with atopic dermatitis. [43]", "contents": "Prurigo Nodularis -- Treatment / Management -- Oral Immunosuppressants. As with topical therapies, no randomized trials have been reported involving these systemic therapies, and the benefits versus risks of the drugs must be considered before beginning treatment. [13] Oral immunosuppressive therapy should be considered for patients with severe, recalcitrant PN. A single-institution retrospective study demonstrated clinical improvement and decreased pruritus with cyclosporine at a mean dose of 3.1 mg/kg. [38] Methotrexate dosed at 5 to 20 mg/kg weekly demonstrated complete or partial remission of 2.4 months. These patients showed a mean duration of response of 19 months. [39] Treatment with azathioprine and cyclophosphamide has also been reported to be successful. [40] [41] Oral tacrolimus therapy dramatically reduced pruritus in a patient previously treated with cyclosporine. [42] Combination therapy of\u00a03 cycles of intravenous immunoglobulin followed by methotrexate and topical steroids was effective in treating PN associated with atopic dermatitis. [43]"}
{"id": "article-27913_25", "title": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments", "content": "Thalidomide is an immunomodulatory agent which also acts as a central and peripheral depressant and inhibits tumor necrosis factor-alpha. [43] The therapeutic effect against\u00a0PN is thought to derive from its neurotoxic effects. [44]", "contents": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments. Thalidomide is an immunomodulatory agent which also acts as a central and peripheral depressant and inhibits tumor necrosis factor-alpha. [43] The therapeutic effect against\u00a0PN is thought to derive from its neurotoxic effects. [44]"}
{"id": "article-27913_26", "title": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments", "content": "Lenalidomide, a more potent molecular form of thalidomide, is effective in\u00a0PN and has a lower frequency of peripheral neuropathy. [45]", "contents": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments. Lenalidomide, a more potent molecular form of thalidomide, is effective in\u00a0PN and has a lower frequency of peripheral neuropathy. [45]"}
{"id": "article-27913_27", "title": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments", "content": "Both selective serotonin reuptake inhibitors and tricyclic antidepressants can also be considered for chronic pruritus. It is also important for patients alsbe seen in conjunction with mental health professionals.", "contents": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments. Both selective serotonin reuptake inhibitors and tricyclic antidepressants can also be considered for chronic pruritus. It is also important for patients alsbe seen in conjunction with mental health professionals."}
{"id": "article-27913_28", "title": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments", "content": "Naloxone and naltrexone exert antipruritic effects by inhibiting Mu-opioid receptors on nociceptive neurons and interneurons, resulting in suppression of itch. [46]", "contents": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments. Naloxone and naltrexone exert antipruritic effects by inhibiting Mu-opioid receptors on nociceptive neurons and interneurons, resulting in suppression of itch. [46]"}
{"id": "article-27913_29", "title": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments", "content": "Neurokinin-1 receptor (NK1r) antagonists, aprepitant and serlopitant, could prevent substance P\u2013mediated signaling in the pathogenesis of PN. [47] Significant relief of itch was achieved in\u00a0PN patients on aprepitant monotherapy.", "contents": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments. Neurokinin-1 receptor (NK1r) antagonists, aprepitant and serlopitant, could prevent substance P\u2013mediated signaling in the pathogenesis of PN. [47] Significant relief of itch was achieved in\u00a0PN patients on aprepitant monotherapy."}
{"id": "article-27913_30", "title": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments", "content": "IL 31 receptor antibody, nemolizumab, significantly improved pruritus scores in patients with moderate to severe atopic dermatitis; however, its role in\u00a0PN remains unclear.", "contents": "Prurigo Nodularis -- Treatment / Management -- Novel Treatments. IL 31 receptor antibody, nemolizumab, significantly improved pruritus scores in patients with moderate to severe atopic dermatitis; however, its role in\u00a0PN remains unclear."}
{"id": "article-27913_31", "title": "Prurigo Nodularis -- Differential Diagnosis", "content": "Due to similar morphologies,\u00a0PN is often confused with and must be clinically separated from: LS\u00a0chronicus HLP Pemphigoid nodularis Nodular scabies Keloids Dermatofibroma Foreign body reactions", "contents": "Prurigo Nodularis -- Differential Diagnosis. Due to similar morphologies,\u00a0PN is often confused with and must be clinically separated from: LS\u00a0chronicus HLP Pemphigoid nodularis Nodular scabies Keloids Dermatofibroma Foreign body reactions"}
{"id": "article-27913_32", "title": "Prurigo Nodularis -- Treatment Planning", "content": "Treatment of\u00a0PN should be tailored to a patient's age, comorbidities, severity of prurigo, quality of life, and expected side effects.", "contents": "Prurigo Nodularis -- Treatment Planning. Treatment of\u00a0PN should be tailored to a patient's age, comorbidities, severity of prurigo, quality of life, and expected side effects."}
{"id": "article-27913_33", "title": "Prurigo Nodularis -- Treatment Planning -- First-line Therapy", "content": "Class\u00a0I topical steroids: Clobetasol propionate 0.05% and halobetasol propionate 0.05%); long-term applications can lead to adverse effects like skin atrophy, folliculitis, miliaria, delayed wound healing, and tachyphylaxis. Intralesional injections: Using triamcinolone acetonide (40 mg/ml); may be accompanied by cryotherapy [48] [49] Topical menthol solution: In a concentration of less than 5%. Systemic antihistamines: Fexofenadine 180 mg, levocetirizine 5 mg, or desloratadine 5 mg during the day, and sedating antihistamines like hydroxyzine 25 mg at night time; first-generation antihistamines cause side effects like sedation, hyperexcitability, impaired cognitive function, dry mouth, constipation, dysuria, tachycardia, and arrhythmias.", "contents": "Prurigo Nodularis -- Treatment Planning -- First-line Therapy. Class\u00a0I topical steroids: Clobetasol propionate 0.05% and halobetasol propionate 0.05%); long-term applications can lead to adverse effects like skin atrophy, folliculitis, miliaria, delayed wound healing, and tachyphylaxis. Intralesional injections: Using triamcinolone acetonide (40 mg/ml); may be accompanied by cryotherapy [48] [49] Topical menthol solution: In a concentration of less than 5%. Systemic antihistamines: Fexofenadine 180 mg, levocetirizine 5 mg, or desloratadine 5 mg during the day, and sedating antihistamines like hydroxyzine 25 mg at night time; first-generation antihistamines cause side effects like sedation, hyperexcitability, impaired cognitive function, dry mouth, constipation, dysuria, tachycardia, and arrhythmias."}
{"id": "article-27913_34", "title": "Prurigo Nodularis -- Treatment Planning -- Second-line Therapy", "content": "Phototherapy: PUVA, long-wavelength UVA, Narrowband UVB, monochromatic excimer light of\u00a0308nm Systemic immunosuppressives: Cyclosporine 3 mg/kg daily; adverse effects include nephrotoxicity, hypertension, hyperlipidemia, hyperkalemia, and hyperuricemia. Methotrexate 5-20 mg/week; common adverse effects are nausea, gastrointestinal symptoms, and transaminitis. Thalidomide: Dosed at 300-400 mg daily yields a good response within 3 months, followed by tapering the dose to 50 mg daily; however, complete cessation of the drug leads to recurrences. Adverse effects are teratogenicity and peripheral neuropathy. Lenalidomide: Dosed at 5-10 mg daily; less neurotoxic than thalidomide. Opioid receptor antagonists: Naltrexone 50 mg daily; adverse effects are restricted to the first 2 weeks of treatment and include nausea, fatigue, dizziness, heartburn, and diarrhea.", "contents": "Prurigo Nodularis -- Treatment Planning -- Second-line Therapy. Phototherapy: PUVA, long-wavelength UVA, Narrowband UVB, monochromatic excimer light of\u00a0308nm Systemic immunosuppressives: Cyclosporine 3 mg/kg daily; adverse effects include nephrotoxicity, hypertension, hyperlipidemia, hyperkalemia, and hyperuricemia. Methotrexate 5-20 mg/week; common adverse effects are nausea, gastrointestinal symptoms, and transaminitis. Thalidomide: Dosed at 300-400 mg daily yields a good response within 3 months, followed by tapering the dose to 50 mg daily; however, complete cessation of the drug leads to recurrences. Adverse effects are teratogenicity and peripheral neuropathy. Lenalidomide: Dosed at 5-10 mg daily; less neurotoxic than thalidomide. Opioid receptor antagonists: Naltrexone 50 mg daily; adverse effects are restricted to the first 2 weeks of treatment and include nausea, fatigue, dizziness, heartburn, and diarrhea."}
{"id": "article-27913_35", "title": "Prurigo Nodularis -- Prognosis", "content": "PN\u00a0is a benign condition with a generally good prognosis. It is a chronic condition, typically preceded by an underlying cause of pruritus. However, PN is a distinct entity from\u00a0the underlying causes and can persist despite the resolution of the predisposing condition.", "contents": "Prurigo Nodularis -- Prognosis. PN\u00a0is a benign condition with a generally good prognosis. It is a chronic condition, typically preceded by an underlying cause of pruritus. However, PN is a distinct entity from\u00a0the underlying causes and can persist despite the resolution of the predisposing condition."}
{"id": "article-27913_36", "title": "Prurigo Nodularis -- Complications", "content": "PN lesions can become secondarily infected due to scratching of the lesions, leading to ulceration, abscess formation, and cellulitis. It is important to monitor for clinical signs of infection, such as erythema, pain, warmth, and fever. If secondary infection is suspected, it is important to begin appropriate topical or systemic antibiotic therapy to cover for skin flora.", "contents": "Prurigo Nodularis -- Complications. PN lesions can become secondarily infected due to scratching of the lesions, leading to ulceration, abscess formation, and cellulitis. It is important to monitor for clinical signs of infection, such as erythema, pain, warmth, and fever. If secondary infection is suspected, it is important to begin appropriate topical or systemic antibiotic therapy to cover for skin flora."}
{"id": "article-27913_37", "title": "Prurigo Nodularis -- Deterrence and Patient Education", "content": "The deterrents in\u00a0PN treatment are the severe intensity of the itch, which can lead to psychological distress, the chronic nature of the condition, the long duration of the therapy, and the potential side effects of the medication.", "contents": "Prurigo Nodularis -- Deterrence and Patient Education. The deterrents in\u00a0PN treatment are the severe intensity of the itch, which can lead to psychological distress, the chronic nature of the condition, the long duration of the therapy, and the potential side effects of the medication."}
{"id": "article-27913_38", "title": "Prurigo Nodularis -- Deterrence and Patient Education", "content": "Discussion with the patient should include the advantages and disadvantages of the therapy, side effects, and possible use of off-label medications. Patient education can thus promote treatment adherence. The potential length of therapy should also be discussed as\u00a0PN is difficult to treat, and the patient may become frustrated with the lack of improvement.", "contents": "Prurigo Nodularis -- Deterrence and Patient Education. Discussion with the patient should include the advantages and disadvantages of the therapy, side effects, and possible use of off-label medications. Patient education can thus promote treatment adherence. The potential length of therapy should also be discussed as\u00a0PN is difficult to treat, and the patient may become frustrated with the lack of improvement."}
{"id": "article-27913_39", "title": "Prurigo Nodularis -- Pearls and Other Issues", "content": "PN\u00a0is a chronic skin disease that can significantly impact a patient's quality of life. Breaking the itch-scratch cycle requires a multifaceted approach, and patients should be encouraged to continue with therapy to reduce scratching and picking at the lesions. It may be necessary to involve behavioral therapy. It is important to explain to patients that PN lesions may be chronic and difficult to completely improve.", "contents": "Prurigo Nodularis -- Pearls and Other Issues. PN\u00a0is a chronic skin disease that can significantly impact a patient's quality of life. Breaking the itch-scratch cycle requires a multifaceted approach, and patients should be encouraged to continue with therapy to reduce scratching and picking at the lesions. It may be necessary to involve behavioral therapy. It is important to explain to patients that PN lesions may be chronic and difficult to completely improve."}
{"id": "article-27913_40", "title": "Prurigo Nodularis -- Enhancing Healthcare Team Outcomes", "content": "Management of PN requires an interprofessional team that includes the primary caregiver, nurse practitioner, dermatologist, and mental health nurse. Patients need to be educated on practices to reduce scratching of lesions, assurance and diagnosing of underlying causes of pruritus, and diagnosis and treatment of any psychological disorder associated with scratching and picking at skin.", "contents": "Prurigo Nodularis -- Enhancing Healthcare Team Outcomes. Management of PN requires an interprofessional team that includes the primary caregiver, nurse practitioner, dermatologist, and mental health nurse. Patients need to be educated on practices to reduce scratching of lesions, assurance and diagnosing of underlying causes of pruritus, and diagnosis and treatment of any psychological disorder associated with scratching and picking at skin."}
{"id": "article-27913_41", "title": "Prurigo Nodularis -- Enhancing Healthcare Team Outcomes", "content": "Topical and systemic treatments are targeted at disrupting the itch-scratch cycle. Patients are encouraged to keep their nails short, wear protective clothing such as long sleeves and gloves, and keep the nodules covered with bandages. Using gentle cleansers to bathe and applying emollients multiple times a day to keep skin moisturized should be encouraged.", "contents": "Prurigo Nodularis -- Enhancing Healthcare Team Outcomes. Topical and systemic treatments are targeted at disrupting the itch-scratch cycle. Patients are encouraged to keep their nails short, wear protective clothing such as long sleeves and gloves, and keep the nodules covered with bandages. Using gentle cleansers to bathe and applying emollients multiple times a day to keep skin moisturized should be encouraged."}
{"id": "article-27913_42", "title": "Prurigo Nodularis -- Enhancing Healthcare Team Outcomes", "content": "Calamine lotions and lotions containing menthol and camphor-like sarna can relieve pruritus. First-generation sedating antihistamines such as hydroxyzine administered at bedtime may be useful in controlling nocturnal pruritus. Both selective serotonin reuptake inhibitors and tricyclic antidepressants can also be considered for chronic pruritus. [12] Finally, the pharmacist should educate the patient on potential adverse reactions to the medications and report to the clinical team if there are complications.", "contents": "Prurigo Nodularis -- Enhancing Healthcare Team Outcomes. Calamine lotions and lotions containing menthol and camphor-like sarna can relieve pruritus. First-generation sedating antihistamines such as hydroxyzine administered at bedtime may be useful in controlling nocturnal pruritus. Both selective serotonin reuptake inhibitors and tricyclic antidepressants can also be considered for chronic pruritus. [12] Finally, the pharmacist should educate the patient on potential adverse reactions to the medications and report to the clinical team if there are complications."}
{"id": "article-27913_43", "title": "Prurigo Nodularis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Prurigo Nodularis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}